DARLENE M DEPTULA-HICKS

CIK 1089409 · See Remarks · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8

Companies

6

Total Filings

24

Lifetime Open-Market Net

-$12.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALDX Director $1.76 $0 1 2026-06-11
F-star Therapeutics, Inc. (FSTX) Delisted See Remarks 25,539 $7.12 $181.8K $0 7 2023-03-09
XBIO Director $3.20 $0 2 2017-06-15
TTOO SVP & Chief Financial Officer 4,000 $0.00 $8 $14.3K 2 2017-06-08
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted SVP, Chief Financial Officer 5,000 $13.60 $68.0K $8.3K 2 2016-06-15
ICAD INC (ICAD) Delisted Exec VP of Finance, CFO 125,055 $3.87 $484.0K -$35.0K 10 2011-03-31

Recent Filings · Page 3 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2009-07-21 ICAD INC (ICAD) Delisted Tax (F) −4,408 -$5.2K EDGAR
2008-07-22 ICAD INC (ICAD) Delisted Tax (F) −4,408 -$12.5K EDGAR
2008-06-27 ICAD INC (ICAD) Delisted Grant (A) +75,000 $0 EDGAR
2007-07-20 ICAD INC (ICAD) Delisted Grant (A) +50,000 $0 EDGAR
Showing 2124 of 24
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.